T Mizutani

No ORCID on file · 5 papers in corpus · active 1989-2022

Study types

  • article 4
  • peer-review 1

Condition tags

  • endometriosis 4
  • bowel_endometriosis 1
peer-review 2022
Peer Review #3 of "BMSC-derived exosomal miR-27a-3p and miR-196b-5p regulate bone remodeling in ovariectomized rats (v0.1)"
·doi:10.7287/peerj.13744v0.1/reviews/3

Background.In the bone marrow microenvironment of postmenopausal osteoporosis (PMOP), bone marrow mesenchymal stem cell (BMSC)-derived exosomal miRNAs play an important role in bone formation and bone resorption, although the pathogenesis h…

article 1999
The gonadotropin-releasing hormone agonist leuprolide acetate induces apoptosis and suppresses cell proliferative activity in rectovaginal endometriosis
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(99)70523-5
article 1995
Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
International journal of fertility and menopausal studies

OBJECTIVE -- The purpose of this study was to compare the potency of the gonadotropin-releasing hormone (GnRH) agonists nafarelin, buserelin, and leuprolide in a newly developed model of experimental endometriosis, thus further characterizi…

article 1990
Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90650-v
article 1989
Studies on GnRH Agonist Suppression of Estrogen Production in Patients with Endometriosis.
Endocrinologia japonica ·doi:10.1507/endocrj1954.36.611

The chronic administration of GnRH agonists to women results in the reversible suppression of estrogen production by the ovary. In the present study, the mechanism of the GnRH agonist suppression of estrogen production was investigated in p…